Organon & Co | OGN - هزینه بهره بدهی

قیمت سهام
6.89
تغییر روزانه
-0.01 -0.14%
ماهیانه
-14.94%
سالیانه
-52.30%
Q1 پیش بینی
7.07




هزینه بهره بدهی تغییر دادن تاریخ
Bristol-Myers Squibb USD 432M 48M 2025-12
Celltrion KRW 19B 1.96B 2025-06
Cspc Pharmaceutical CNY 10.19M 4.73M 2025-09
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 30M 2025-12
Gilead Sciences USD 255M 1000K 2025-12
Glaxosmithkline GBP 177.95M 6.05M 2025-09
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 2.37M 6K 2025-09
Laboratorios Farma EUR 699K 666.2K 2025-06
Medical Developments International AUD 18K 3K 2025-06
Merck USD 412M 85M 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-06
Novartis USD 281M 8M 2025-09
Organon & Co USD 128M 3M 2025-09
Ovoca Bio EUR 7K 6K 2022-06
Pharma Mar EUR 117K 1.24M 2025-09
Qiagen NV USD 10.14M 1.92M 2025-12
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tilray USD 6.7M 2.73M 2025-06